We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

FOR PREVIEW ONLY (Print)

Anat Ben-Shlomo, MD

Advanced Health Sciences Pavilion
127 S. San Vincente Blvd.
Los Angeles, CA 90048

Phone:

310-423-2830

Anat Ben-Shlomo, MD

  • IM/Endocrinology

Acromegaly

Addison's Disease

Adrenal Gland Disorders

Adrenal Hyperplasia (Late Onset)

Androgen Disorders

Cushing's Disease

Hormone Replacement Therapy (HRT)

Hypopituitarism

Menstrual Disorders

Osteopenia (Low Bone Density)

PCOS (Polycystic Ovary Syndrome)

Pituitary Disorders

Pituitary Tumors

Prolactinoma

Thyroid Disorders

The research of Anat Ben-Shlomo, MD, focuses on clinical and translational-basic research in pituitary and the adrenal gland disorders, with special emphasis on pituitary tumor genomics and therapies, somatostatin biology and somatostatin analog therapy, and adrenal insufficiency diagnosis and therapy.

  • Medical School: Sackler Faculty of Medicine, 1993
  • Residency: Assaf HaRofeh Medical Center, 1997
  • Fellowship: Assaf HaRofeh Medical Center, 2000
  • Post Doctorate: Cedars-Sinai, 2004
  • Rotary International Professional Excellence Award, Tel Aviv University
  • Corrine and Lenny Sands Clinical Investigator Award, Cedars-Sinai

Click here for a list of peer-reviewed publications.

  • Ben-Shlomo A, Wawrowsky KA, Miklovsky I, Ren SG, Taylor J, Culler MD, Melmed S. Somatostatin receptor type 5 modulates somatostatin receptor type 2 regulation of ACTH secretion. J Biol Chem. 2005;280(25):24011-24021.
  • Ben-Shlomo A, Schmid H, Wawrowsky K, Hubina E, Pichurin O, Chesnokova V, Liu NA, Culler M, Melmed S. Differential ligand-mediated pituitary somatostatin receptor subtype signaling: Implications for cortictroph tumor therapy. J Clin Endocrinol Metab. 2009;94(11):4342-4350.
  • Ben-Shlomo A, Pichurin O, Khalafi R, Zhou C, Chesnokova V, Ren SG, Liu NA, Melmed S. Constitutive somatostatin receptor subtype 2 activity attenuates growth hormone synthesis. Endocrinology. 2013;154(7):2399-2409.
  • Chesnokova V, Zhou C, Ben-Shlomo A, Zonis S, Tani Y, Ren SG, Melmed S. Growth hormone is a cellular senescence target in pituitary and non-pituitary cells. Proc Natl Acad of Sci USA. 2013;27;110(35):E3331-3339.
  • Ben-Shlomo A, Mirocha J, Gwin S, Khine A, Liu NA, Sheinin R, Melmed S. Clinical factors associated with biochemical adrenal-cortisol insufficiency in hospitalized patients. Am J Med. 2014;127(8):754-762.
  • Eigler T, Ben-Shlomo A. Somatostatin system regulation of hormone-secreting cells in anterior pituitary cells: Molecular mechanisms and functional outcomes. J Mol Endocrinol. 2014;53(1):R1-19.

Show moreShow less

English / Hebrew

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.

Send Email to Anat Ben-Shlomo, MD